Why Medtronic Stock Got Off to a Roaring Start This Week
It isn't unusual for top medical device maker (NYSE: MDT) to score regulatory approvals for its goods. Nevertheless, in the healthcare field, nearly any regulatory win is considered a convincing victory for the company behind the product.
That was the dynamic behind the more than 2% bump in share price Medtronic enjoyed on Monday. That performance topped the broader stock market, at least if we go by the 1.4% rise of the benchmark S 500 index.
Early Monday afternoon, Medtronic reported that its Percept RC Deep Brain Stimulation (DBS) system had received approval from the U.S. Food and Drug Administration (FDA).
Source Fool.com
Medtronic plc Stock
€75.89
0.720%
With 10 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 94 € shows a positive potential of 23.86% compared to the current price of 75.89 € for Medtronic plc.
